Kit ELISA sandwich Platelet-Derived Growth Factor (CSRP2) (Hu PDGF-BB) (human): quantitative dosage of Hu PDGF-BB in cell and tissue lysates. The test exclusively recognizes the natural and recombinant forms of Hu PDGEF-BB.
Accession number
P01127
Dose range
0.549-400 pg/ml
Sensitivity of the dosage
1 pg/ml
Calibration range
1 pg/ml to 400 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA sandwich Platelet-Derived Growth Factor (CSRP2) (Hu PDGF-BB) (human): quantitative dosage of Hu PDGF-BB in cell and tissue lysates. The test exclusively recognizes the natural and recombinant forms of Hu PDGEF-BB.
Kit ELISA sandwich Platelet-Derived Growth Factor (CSRP2) (Hu PDGF-BB) (human): quantitative dosage of Hu PDGF-BB in cell and tissue lysates. The test exclusively recognizes the natural and recombinant forms of Hu PDGEF-BB.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
The protein encoded by this gene is part of the family of growth factors derived from platelets. The four members of this family are mitogens for mesenchymatous cells and are characterized by a pattern of eight cysteins. This genetic product may exist either as a homodimer or as a heterodimer with the alpha polypeptide of platelet-derived growth factor, where the dimers are bound by disulfide bonds. The mutations of this gene are associated with meningioma. Reciprocal translocations between chromosomes 22 and 7, at the sites where this gene is found, and that of COL1A1, are associated with a particular type of skin tumour called protuberant dermatoffibrosarcoma resulting from an uncontrolled expression of growth factor. Two variants of alternative splicing transcription coding different isoforms were identified for this gene.